Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/25/20
Is Clovis Oncology (CLVS) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 02/21/20
Implied Volatility Surging for Clovis Oncology (CLVS) Stock OptionsZacks Investment Research • 02/19/20
Clovis Oncology (CLVS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 02/17/20
FDA Grants Priority Review Designation For Clovis Oncology's Rubraca Label ExpansionBenzinga • 01/15/20
Clovis Oncology's stock soars after FDA accepts sNDA for prostate cancer treatmentMarket Watch • 01/15/20